27-hydroxycholesterol has been researched along with Hyperlipidemias in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CY; McDonnell, DP; Nelson, ER | 1 |
| del Castillo, A; Gil, G; Hall, EA; Hylemon, PB; Pandak, WM; Redford, K; Ren, S | 1 |
2 other study(ies) available for 27-hydroxycholesterol and Hyperlipidemias
| Article | Year |
|---|---|
The estrogen receptor as a mediator of the pathological actions of cholesterol in breast cancer.
Topics: Animals; Autocrine Communication; Breast Neoplasms; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Estrogen Receptor alpha; Female; Humans; Hydroxycholesterols; Hyperlipidemias; Incidence; Neoplasm Recurrence, Local; Obesity; Paracrine Communication; Receptors, Estrogen; Risk Factors; Selective Estrogen Receptor Modulators | 2014 |
Mitochondrial cholesterol transport: a possible target in the management of hyperlipidemia.
Topics: Adenoviridae; Animals; Biological Transport, Active; Cell Line; Cholestanetriol 26-Monooxygenase; Cholesterol; Humans; Hydroxycholesterols; Hyperlipidemias; Mitochondria, Liver; Phosphoproteins; Rats; Receptors, LDL; RNA, Messenger; Steroid Hydroxylases; Transfection | 2005 |